Umoja Biopharma, Inc

AltPep Corporation, based in Seattle, WA, is a pioneering biotechnology company focused on transforming the diagnosis and treatment of amyloid diseases, including Alzheimer's and Parkinson's. By targeting early molecular triggers, AltPep aims to enable earlier interventions that could significantly change disease progression for over a billion people worldwide. The company's innovative platform relies on a growing library of custom-designed synthetic peptides that selectively bind to toxic soluble oligomers, facilitating both detection and neutralization throughout disease progression. With promising developments in diagnostics and therapeutics, AltPep is committed to making breakthrough advancements in the early detection and modification of amyloid diseases. Generated from the website

HDT Bio Corp is a Seattle-based company focused on developing transformative technologies in the biosciences sector. The company is committed to fostering partnerships with investors and collaborators who share their vision of impactful innovation. With a dedicated team of scientists and business professionals, HDT Bio prides itself on a collaborative work environment that embraces both successes and challenges. The company actively seeks enthusiastic individuals to join their mission and contribute to their ongoing projects. Generated from the website

Adaptive Biotechnologies Corporation, based in Seattle, WA, is a pioneering company at the forefront of immune medicine. By harnessing the power of the adaptive immune system, they are revolutionizing diagnostic and therapeutic approaches to detect and treat diseases. Their innovative products, such as minimal residual disease testing and immune receptor data analysis, are driving a paradigm shift in medicine. Through their cutting-edge technology and research, Adaptive Biotechnologies is leading the way in transforming how diseases are detected and treated. Generated from the website